Population Health Investment Co., Inc. Warrant
PHICW
PHICW was delisted on the 29th of November, 2022.
0 hedge funds and large institutions have $0 invested in Population Health Investment Co., Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.
100% less funds holding
Funds holding: 30 → 0 (-30)
100% less capital invested
Capital invested by funds: $2.76M → $0 (-$2.76M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 29
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1.78M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$828K |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
-$50K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$16K |
| 5 |
SC
Sculptor Capital
New York
|
-$13K |
PHICW Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Population Health Investment Co., Inc. Warrant (PHICW) for Q4 2022, worth a combined $0 — down 100% from $2.76M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of PHICW and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.78M sold.
- 0 institutional investors held Population Health Investment Co., Inc. Warrant (PHICW) as of Q4 2022, down from 30 in Q3 2022.
- Funds reported $0 of Population Health Investment Co., Inc. Warrant stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Population Health Investment Co., Inc. Warrant positions in Q4 2022 and 29 closed out, a net change of -29 holders.
- The largest Population Health Investment Co., Inc. Warrant seller in Q4 2022 was Radcliffe Capital Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q4 2022.